en

PRODUCT DETAIL

QINLOCK 50 mg tablety

Code 9126D
MA number EU/1/21/1569/002
Product Form: tbl 90x50 mg (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EX Other protein kinase inhibitors
L01EX19 Ripretinib
Shelf life: 36
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 18.11.2021
Validity: 18.11.2026
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 29.11.2021
eu-flag.png sk-flag.png